Loading company details...
Latest Form 4 (May 5, 2026): Robert Azelby (Director): Disposition to Issuer of 90,000 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| May 5, 2026 | Robert Azelby | Disposition to Issuer | 90,000 | n/a |
| May 5, 2026 | Heather D. Turner | Disposition to Issuer | 45,000 | n/a |
| May 5, 2026 | Radhika Tripuraneni | Disposition to Issuer | 64,000 | n/a |
| May 5, 2026 | Jill M. Quigley | Disposition to Issuer | 45,000 | n/a |
| May 5, 2026 | Jeffrey B. Kindler | Disposition to Issuer | 32,000 | n/a |
| May 5, 2026 | David A. Fellows | Disposition to Issuer | 32,000 | n/a |
| May 5, 2026 | Emil Kuriakose, Chief Medical Officer | Tender of Shares | 24,562 | $1.30M |
| May 5, 2026 | Andrew Gengos, Chief Financial Officer | Tender of Shares | 40,503 | $2.15M |
| May 5, 2026 | Amy L. Burroughs, Chief Executive Officer | Tender of Shares | 146,614 | $7.77M |
| Apr 2, 2026 | Emil Kuriakose, Chief Medical Officer | Sale | 942 | $49.7K |